2023 Financial Disclosures - PPPC
David K. Wallace, MD, MPH, Chair
National Eye Institute - S
Christina J. Flaxel, MD
No financial relationships to disclose
Deborah S. Jacobs, MD
Cloudbreak Pharma - C
Dompe - C
TecLens LLC - PS, C
UpToDate, Inc. - P
Francis S. Mah, MD
Bausch and Lomb, Dompe, GSK, Novartis, Sun Pharma - L
Alcon Laboratories, Inc., Aldeyra Therapeutics, Allergan, Aperta, Avellino Labs, Bausch and Lomb, Dermavent, Dompe, Evolve, EyeYon, GSK, Johnson & Johnson, KALA Pharmaceuticals, Kiora, Mallinckrodt Pharmaceuticals, Novartis, NuLids, Ocular Therapeutix, OcuTerra, Okogen, PolyActiva, Slack Publishing, Sun Pharma, Sydnexis, Tarsus, TearLab - C
Slack Publishing - P
Sydnexis - SO
Ocular Therapeutix - S
Steven J. Gedde, MD
No financial relationships to disclose
Kevin M. Miller, MD
Alcon Laboratories, Inc., Johnson & Johnson Vision, Oculus, Inc. - C
Johnson & Johnson Vision - S
Thomas A. Oetting, MD
No financial relationships to disclose
Divya M. Varu, MD
No financial relationships to disclose
David C. Musch, PhD, MPH, Methodologist
ONL Therapeutics, Regulatory Pathway Groups, Inc. - C
Centers for Disease Control, National Eye Institute, Fogarty International Center, National Institute of Health - S
KEY:
C = Consultant/Advisor (consultant fee, paid advisory boards or fees for attending a meeting [for the past 1 year])
E = Employee (employed by a commercial entity)
L = Lecture Fees (lecture fees [honoraria], travel fees or reimbursement when speaking at the invitation of a commercial entity
O = Equity Owner
S = Grant Support
P = Patents/Royalties
PS = Equity/Stock Options Holder - Private Corp
US = Equity/Stock Options Holder - Public Corp